Cure pharmaceutical letter to shareholders

Investment in new marketing strategies showing encouraging early results enhanced instagram & media campaigns featuring nicole kidman highlighting seratopical revolution incubator strategy initiated with new market disruptor products arriving 1h2023 sherman oaks, ca / accesswire / december 15, 2022 / cure pharmaceutical holding corp. (otcqb:curr) ceo nancy duitch is providing an update to its shareholders on positive recent developments in the evolution and progress of the company. dear shareholders: we would like to thank all of you for your continued support during this exciting time in our company's history.
CURR Ratings Summary
CURR Quant Ranking